UCB is a global biopharma company that is driven by the needs of people living with severe diseases. With a strong focus on neurology, immunology, and other areas, UCB is committed to improving the lives of those facing challenging conditions. Their mission is to allow individuals to live their best lives, as free as possible from the burdens of disease.

UCB's success is driven by their dedicated team of approximately 8,700 professionals worldwide, who have been passionately serving patients since 1928. UCB's strategy centers around delivering valuable solutions to people with severe diseases by understanding their needs beyond just treatment. They prioritize dialogue, collaboration, and respect to forge strong bonds with patients and those who understand their challenges, leading to impactful outcomes.

UCB also believes in the power of partnerships, working closely with academia and industry peers to address critical challenges. With a rich history and a strong focus on innovation, UCB is continuously developing new medicines and solutions to drive future growth. Their commitment to connecting patients to science sets them apart, ensuring that their work has a tangible and positive impact on the lives of those they serve.

Discover more about UCB and their transformative approach to healthcare on their global corporate website